03 July 2017 | News
As part of this deal MMC Pharma's offshoot InnoBioLabs LLP will be investing over $ 300,000 in setting up 10 autologous therapeutic processing labs across Kerala & Tamil Nadu.
Innov4Sight Health and Biomedical Systems Private Limited, a Bangalore based startup, has inked a strategic licensing deal with MMC Pharmaceuticals. This deal will generate more $ 3 Million over the next 18 months.
As part of this deal MMC Pharma's offshoot InnoBioLabs LLP will be investing over $ 300,000 in setting up 10 autologous therapeutic processing labs across Kerala & Tamil Nadu. Innov4Sight will now be following this with similar deals in Madhya Pradesh and a few other States.
Innov4Sight started in 2014 on an epiphany moment to reduce errors, second guesses and improve effective care impacting Fertility & Cancer Care.
The company intends to create an ecosystem of direct and complementary solutions in the fertility and cancer care space, spearheading innovation that reduces error rate, enhances effectiveness of treatments and replaces second guessing with data backed insights.
MMC Pharmaceuticals Ltd develops and provides healthcare in the areas of Gastroenterology, General Health, Neuropathy, Pain Management, Allergy & Asthma Prevalence, Women & Child Health as well as other symptomatic conditions treated by specialists.
MMC Pharma is an asset light organization focused only on marketing and the production part of the business is outsourced from quality pharmaceutical factories throughout India and also from global companies. Currently the company is focused on Neurology, Respiratory, Gynecology and infertility therapy areas and will be expanding to other therapy areas at appropriate time.